Global Whole Exome Sequencing Market 2023
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global drug discovery market is likely to register a CAGR of over 8.7% with an incremental growth of USD 44 billion during the forecast period 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global drug discovery market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the drug discovery industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, drug type, disease application, end user, and region. The global market for drug discovery can be segmented by type: bioanalytical instruments, bioinformatics, cell-based assays and reagents, genomics, high-throughput screening, proteomics, others. The bioanalytical instruments segment captured the largest share of the market in 2021. Drug discovery market is further segmented by drug type: biologics, small-molecule drugs. Based on disease application, the drug discovery market is segmented into: cancer, cardiovascular, immunological, neurological, others. In 2021, the cancer segment made up the largest share of revenue generated by the drug discovery market. On the basis of end user, the drug discovery market also can be divided into: academia and research institutes, contract research organizations (CROs), pharmaceutical companies. Drug discovery market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By type:
– bioanalytical instruments
– bioinformatics
– cell-based assays and reagents
– genomics
– high-throughput screening
– proteomics
– others
By drug type:
– biologics
– small-molecule drugs
By disease application:
– cancer
– cardiovascular
– immunological
– neurological
– others
By end user:
– academia and research institutes
– contract research organizations (CROs)
– pharmaceutical companies
By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The report also provides a detailed analysis of several leading drug discovery market vendors that include Agilent Technologies Inc., AMETEK, Inc., Arrayit Corp., Becton, Dickinson and Company, Biomax Informatics AG, Bio-Rad Laboratories, Inc., Bruker Corp., Charles River Laboratories, Inc., Danaher Corp., General Electric Company (GE), Hitachi High-Technologies Corporation, Illumina, Inc., JEOL Ltd., LECO Corporation, Merck KGaA, Perkin Elmer Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global drug discovery market.
– To classify and forecast the global drug discovery market based on type, drug type, disease application, end user, region.
– To identify drivers and challenges for the global drug discovery market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global drug discovery market.
– To identify and analyze the profile of leading players operating in the global drug discovery market.
Why Choose This Report
– Gain a reliable outlook of the global drug discovery market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TYPE
· Bioanalytical instruments
· Bioinformatics
· Cell-based assays and reagents
· Genomics
· High-throughput screening
· Proteomics
· Others
PART 6. MARKET BREAKDOWN BY DRUG TYPE
· Biologics
· Small-molecule drugs
PART 7. MARKET BREAKDOWN BY DISEASE APPLICATION
· Cancer
· Cardiovascular
· Immunological
· Neurological
· Others
PART 8. MARKET BREAKDOWN BY END USER
· Academia and research institutes
· Contract research organizations (CROs)
· Pharmaceutical companies
PART 9. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 10. KEY COMPANIES
· Agilent Technologies Inc.
· AMETEK, Inc.
· Arrayit Corp.
· Becton, Dickinson and Company
· Biomax Informatics AG
· Bio-Rad Laboratories, Inc.
· Bruker Corp.
· Charles River Laboratories, Inc.
· Danaher Corp.
· General Electric Company (GE)
· Hitachi High-Technologies Corporation
· Illumina, Inc.
· JEOL Ltd.
· LECO Corporation
· Merck KGaA
· Perkin Elmer Inc.
· Qiagen N.V.
· Roche Holding AG
· Shimadzu Corporation
· Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Agilent Technologies Inc.
AMETEK, Inc.
Arrayit Corp.
Becton, Dickinson and Company
Biomax Informatics AG
Bio-Rad Laboratories, Inc.
Bruker Corp.
Charles River Laboratories, Inc.
Danaher Corp.
General Electric Company (GE)
Hitachi High-Technologies Corporation
Illumina, Inc.
JEOL Ltd.
LECO Corporation
Merck KGaA
Perkin Elmer Inc.
Qiagen N.V.
Roche Holding AG
Shimadzu Corporation
Thermo Fisher Scientific Inc.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
CAGR (2022-2028) | 8.7% |
Pages | 91 |
Key Players | Agilent Technologies Inc., AMETEK Inc., Arrayit Corp., Becton Dickinson and Company, Biomax Informatics AG, Bio-Rad Laboratories Inc., Bruker Corp., Charles River Laboratories Inc., Danaher Corp., General Electric Company (GE), Hitachi High-Technologies Corporation, Illumina Inc., JEOL Ltd., LECO Corporation, Merck KGaA, Perkin Elmer Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Thermo Fisher Scientific Inc. |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.